'Secure growth companies could be toppled by turnaround stories'
Likes healthcare and technology
Set to start trading on Friday 2 December
Rallied following Clinton defeat
'Shock Trump victory would lead to discounts widening'
Headlines and politics are driving healthcare. We see the outcome of the US election in a little over a week's time as a factor to guide investors within the sector - and not as a reason to avoid the sector overall.
Sister for BB Biotech trust
Clinton vowed to tackle drug prices
Possible pricing changes
Four funds for global themes
Latest roundup by QuotedData
The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.
Trump and Clinton fight for presidency
The airline industry is one of the safest in the world, which always seems a fairly ironic statement given some of the air disasters that have made the news in recent years.
Deadline of 27 June
Easy to become 'despondent' over Japan
Following the crescendo of the European sovereign debt crisis in 2011, scepticism plagued investors across the continent, leaving the economy in a fragile, lethargic state.
Changing role of health insurers
Healthcare was one sector that did not fully participate in the recent stockmarket rally and finished the first quarter as the worst performer in the S&P 500 index, writes Legg Mason's Evan Bauman.
Americans are an optimistic bunch by nature. However, talk of secular stagnation, declining opportunities and faltering growth have become the topics de jour.
Winterflood's latest review
Biotech has fallen
It is hard to think of the 'positives' of an ageing population in the UK, writes Lawrence Gosling.
Tom Delic, assistant fund manager at Seneca Investment Managers explores the demographic trends - from opportunities in tech to wealth management - that are available for investors to take advantage of